Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Vikrant Saluja"'
Autor:
Vikrant Saluja, Bhupinder Singh Sekhon
Publikováno v:
Journal of Excipients and Food Chemicals, Vol 4, Iss 3 (2016)
Pharmaceutical excipients are vital components of drug formulations and are generally considered pharmacologically inert. Control of excipient manufacturing and distribution is now considered a key priority by regulatory authorities and pharmaceutica
Externí odkaz:
https://doaj.org/article/52b4d3046745409e940ca3901fad07da
Autor:
Vikrant Saluja, R. Jayakumararaj, L. Ramanathan, Devaraj Aruna, G. Grace Lydial Pushpalatha, K. Kavipriya, R. Priyanka, M. Chandran, T. Loganathan, S. Ramya
Publikováno v:
Journal of Drug Delivery and Therapeutics. 12:110-118
Seeds of cumin (Cuminum cyminum L.) are widely used as a spice for their distinctive aroma. C. cyminum have been used in traditional medicine to treat a variety of diseases. Literature presents ample evidence for biomedical activities of cumin which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3708ce9f81f648b337a1b10fde79ec84
https://doi.org/10.22270/jddt.v12i2-s.5280
https://doi.org/10.22270/jddt.v12i2-s.5280
Publikováno v:
Journal of Drug Delivery Science and Technology. 52:15-26
Optimization of biological performance of a carrier in cancer drug delivery depends on the targeting potential of the delivery system and its ability to control the drug release precisely. Dendrimers has emerged as a potential carrier of anticancer d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd6f3821049ae606fec1d77c384dd65e
https://doi.org/10.1016/j.jddst.2019.04.014
https://doi.org/10.1016/j.jddst.2019.04.014
Publikováno v:
International journal of pharmaceutics. 600
Cancer is a known deadliest disease that requires a judicious diagnostic, targeting, and treatment strategy for an early prognosis and selective therapy. The major pitfalls of the conventional approach are non-specificity in targeting, failure to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb271ae98ee2959c1f1b0761ab030e0
https://pubmed.ncbi.nlm.nih.gov/33744447
https://pubmed.ncbi.nlm.nih.gov/33744447
Autor:
S., Ramya, T., Loganathan, M., Chandran, R., Priyanka, K., Kavipriya, Pushpalatha G., Grace Lydial, Devaraj, Aruna, L., Ramanathan, R., Jayakumararaj, Vikrant, Saluja
Publikováno v:
Journal of Drug Delivery & Therapeutics; 2022 Supplement, Vol. 12, p110-1118, 1009p
Publikováno v:
Current pharmaceutical design. 22(42)
The regulatory paradigm is relaxing gradually without compromising the safety, efficacy and the quality of the drug product and, most importantly, a perceptible scientific consensus is maturing towards the need of affordable medicines. The establishm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::995cdd0478ac874c41ff95af42ffaea1
https://pubmed.ncbi.nlm.nih.gov/27396596
https://pubmed.ncbi.nlm.nih.gov/27396596
Autor:
Vikrant Saluja, Bhupinder Singh Sekhon
Publikováno v:
Biosimilars. 1:1-11
Bhupinder Singh Sekhon, Vikrant SalujaInstitute of Pharmacy, PCTE Group of Institutes, Near Baddowal Cantt. (Ludhiana), IndiaAbstract: “Biologics”, considered one of the fastest growing sectors of the pharmaceutical industry, has introduced many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0101952e74b6d6f1a45746ffbe0604e3
https://doi.org/10.2147/bs.s16120
https://doi.org/10.2147/bs.s16120
Publikováno v:
Current drug delivery. 12(2)
An important step in oral drug development is to identify drug candidates that show sufficient aqueous solubility and could resist or bypass first-pass metabolism in order to overcome bioavailability problems. Aqueous solubility is characteristically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba0fe2f1a15e2393c730089378d6a34
https://pubmed.ncbi.nlm.nih.gov/25911165
https://pubmed.ncbi.nlm.nih.gov/25911165
Autor:
Vikrant Saluja, Parikshit Bansal, Monica Gulati, Dimple Sethi Chopra, Purnima Pathak, Sachin Kumar Singh
Publikováno v:
Recent patents on CNS drug discovery. 8(3)
The blood-brain barrier (BBB) presents a combination of physical and electrostatic barriers. It is a highly complex structure that tightly regulates the movement of molecules from the blood to brain, protecting it from injuries and diseases. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b144af722f3d285cefbe61d9cb81f7ad
https://pubmed.ncbi.nlm.nih.gov/24286450
https://pubmed.ncbi.nlm.nih.gov/24286450
Publikováno v:
Recent patents on CNS drug discovery. 3(3)
The brain is one of the least accessible organs of the body, thus making the delivery of neurotherapeutics almost a challenge. Despite its relatively high nutrient support and exchange requirements, the uptake of any compound is strictly regulated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e75aa640cf080f3c81fc38d8da9413
https://pubmed.ncbi.nlm.nih.gov/18991811
https://pubmed.ncbi.nlm.nih.gov/18991811